IDRI and Chembio Collaborate to Develop a Low-Cost Test for Visceral Leishmaniasis
SEATTLE and NEW YORK, May 11 /PRNewswire-USNewswire/ -- The Infectious Disease Research Institute (IDRI) and Chembio
Diagnostics Systems, Inc. (Chembio) today announced they have entered into a milestone-based agreement pursuant to which Chembio
will use its patented dual path platform technology...
IDRI and Chembio to Develop Tests for Leishmaniasis and Leprosy
The Seattle-based Infectious Disease Research Institute (IDRI) and Chembio
Diagnostics, Inc. (OTC Bulletin Board: CEMI) have entered into two research and development agreements for the development of rapid diagnostic tests for Leishmaniasis and Leprosy, two 'neglected diseases' targeted by IDRI. ...
Chembio in Biological Technology
The Bill & Melinda Gates Foundation, BIO, and Bio Ventures for Global Health Invite Proteome Systems' CEO to Speak on TB Diagnostics Solutions At Partnering for Global Health Forum, Washington D.C.
...President, BD Medical, BD;
Jean-Francois de Lavison, President, European Diagnostic Manufacturers
Association; Lawrence A. Siebert, President and CEO, chembio
Inc., and Karen Hedine, President and CEO, Micronics.
Dr Harry said rapid and accurate diagnosis is critical to arrest
transmission and ...
Chembio in other areas
Chembio Diagnostic Systems, Inc.Chembio
Awarded Three-Year $3MM NIH SBIR Phase II Grant to Complete DPP® Test ... IDRI and Chembio
Collaborate to Develop a Low-Cost Test for Visceral Leishmaniasis ...
in Additional Technology Pacts With Oswaldo Cruz Foundation ... Chembio
is an important partner in this area and we hope to strengthen this ...
ABOUT US CONTACTS ChemBio
.org. Scientific consulting Planning and budgeting ... ChemBio
- ABOUT US "FROM CONSULTING TO R&D" ... Top. ChemBio
.Org 2007 ...
The Chemical Biology Interdisciplinary Doctoral Program at Michigan coalesces faculty in chemical biology from a number of departments into a single training ...